LGALS8 抗体 (AA 281-359)
Quick Overview for LGALS8 抗体 (AA 281-359) (ABIN758636)
抗原
See all LGALS8 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 281-359
-
交叉反应
- 小鼠
-
预测反应
- Human,Rat
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human LGALS8
-
亚型
- IgG
-
-
-
-
应用备注
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- LGALS8 (Lectin, Galactoside-Binding, Soluble, 8 (LGALS8))
-
别名
- Galectin 8
-
背景
-
Synonyms: Gal 8, Gal-8, Gal8, Galectin-8, LEG8_HUMAN, LGAL S8, LGALS8, PCTA 1, PCTA-1, PCTA1, Po66 carbohydrate binding protein, Po66 carbohydrate-binding protein, Po66 CBP, Po66-CBP, Prostate carcinoma tumor antigen 1.
Background: Galectin 8
-
基因ID
- 3964
-
UniProt
- O00214
抗原
-